![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
SD Ray, VR Mumaw, RR Raje and MW Fariss
Department of Pharmacology, Toxicology & Medicinal Chemistry, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, New York, USA.
This study of acetaminophen (AAP) hepatotoxicity examined whether some aspects of the highly integrated process of drug-induced toxicity involves apoptosis, in addition to necrosis in vivo; and if so, whether cholesteryl hemisuccinate (CS) pretreatment would selectively interfere with apoptotic or necrotic liver cell death. We have previously demonstrated that CS preexposure in vivo, protects hepatocellular necrosis and necrosis-related events induced by carbon tetrachloride (CCl4) administration. Our study demonstrates that administration of hepatotoxic doses of AAP (350-500 mg/kg, i.p.) to ICR mice (CD-1) results in severe liver injury leading to cell death both by necrosis and apoptosis. AAP-induced cell death was preceded by massive elevation in serum alanine aminotransferase coupled with rapid loss of large genomic DNA (2-24 hr), fragmentation of DNA in the form of a ladder (2- 24 hr), apoptotic nuclear condensation at early hours (2-6 hr) followed by massive fragmentation and margination of heterochromatin at later (6- 24) hours and a near total loss of glycogen in pericentral areas. Although CS (100 mg/kg, i.p.) alone had no noticeable biochemical or morphological effects, its administration before AAP (350-500 mg/kg, i.p.) abrogated histological and biochemical diagnostics of both apoptosis and necrosis. These include near total absence of loss of large genomic DNA and glycogen, and dramatic protection from escalating levels of liver injury. CS pretreatment also arrested AAP-induced ultrastructural changes typical of both apoptosis and necrosis. Histopathological examination of periodic acid-Schiff stained liver sections mirrored the biochemical and ultrastructural findings. In conclusion, this study for the first time establishes that apoptosis, in addition to necrosis, significantly contributes to AAP hepatotoxicity in vivo, and preexposure of mice to CS prevents AAP- induced hepatic apoptosis and necrosis.
This article has been cited by other articles:
|
|
 |
|
  B. Hu and L. M. Colletti Stem cell factor and c-kit are involved in hepatic recovery after acetaminophen-induced liver injury in mice Am J Physiol Gastrointest Liver Physiol, July 1, 2008; 295(1): G45 - G53. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Heinloth, G. A. Boorman, J. F. Foley, N. D. Flagler, and R. S. Paules Gene Expression Analysis Offers Unique Advantages to Histopathology in Liver Biopsy Evaluations Toxicol Pathol, February 1, 2007; 35(2): 276 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Jaeschke and M. L. Bajt Intracellular Signaling Mechanisms of Acetaminophen-Induced Liver Cell Death Toxicol. Sci., January 1, 2006; 89(1): 31 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Martin and P.-G. Forkert Evidence That 1,1-Dichloroethylene Induces Apoptotic Cell Death in Murine Liver J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 33 - 42. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A H McGregor, L J More, K J Simpson, and D J Harrison Liver death and regeneration in paracetamol toxicity Human and Experimental Toxicology, April 1, 2003; 22(4): 221 - 227. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. ISHIDA, T. KONDO, T. OHSHIMA, H. FUJIWARA, Y. IWAKURA, and N. MUKAIDA A pivotal involvement of IFN-{gamma} in the pathogenesis of acetaminophen-induced acute liver injury FASEB J, August 1, 2002; 16(10): 1227 - 1236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Gujral, T. R. Knight, A. Farhood, M. L. Bajt, and H. Jaeschke Mode of Cell Death after Acetaminophen Overdose in Mice: Apoptosis or Oncotic Necrosis? Toxicol. Sci., June 1, 2002; 67(2): 322 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Adams, R. H. Pierce, M. E. Vail, C. C. White, R. P. Tonge, T. J. Kavanagh, N. Fausto, S. D. Nelson, and S. A. Bruschi Enhanced Acetaminophen Hepatotoxicity in Transgenic Mice Overexpressing BCL-2 Mol. Pharmacol., November 1, 2001; 60(5): 907 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Waters, J. H. Wang, H. P. Redmond, Q. D. Wu, E. Kay, and D. Bouchier-Hayes Role of taurine in preventing acetaminophen-induced hepatic injury in the rat Am J Physiol Gastrointest Liver Physiol, June 1, 2001; 280(6): G1274 - G1279. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-F. Wang, X. Ren, J. DeAngelis, J. Min, Y. Zhang, T. G. Hampton, I. Amende, and J. P. Morgan Differential Patterns of Cocaine-Induced Organ Toxicity in Murine Heart versus Liver Experimental Biology and Medicine, January 1, 2001; 226(1): 52 - 60. [Abstract] [Full Text]
|
|
|
|
|
|
F. A. Nicholls-Grzemski, I. C. Calder, B. G. Priestly, and P. C. Burcham Clofibrate-Induced in Vitro Hepatoprotection against Acetaminophen Is Not Due to Altered Glutathione Homeostasis Toxicol. Sci., July 1, 2000; 56(1): 220 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Hogaboam, C. L. Bone-Larson, M. L. Steinhauser, A. Matsukawa, J. Gosling, L. Boring, I. F. Charo, K. J. Simpson, N. W. Lukacs, and S. L. Kunkel Exaggerated Hepatic Injury Due to Acetaminophen Challenge in Mice Lacking C-C Chemokine Receptor 2 Am. J. Pathol., April 1, 2000; 156(4): 1245 - 1252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Proceedings of the British Toxicology Society Annual Congress University of Surrey, Guildford 19 - 22 April 1998 Human and Experimental Toxicology, September 1, 1998; 17(9): 469 - 534. [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
